Quipt Home Medical Wins Final Court Approval for $3.65-Per-Share Buyout

Reuters03-06 09:30
Quipt Home Medical Wins Final Court Approval for $3.65-Per-Share Buyout

Affiliates of Kingswood Capital Management and Forager Capital Management are set to acquire all outstanding shares of Quipt Home Medical Corp. for US$3.65 per share in cash, after Quipt said it received a final court order approving the deal. Quipt expects the transaction to close by March 16, 2026, subject to remaining conditions, and anticipates its shares will be delisted from the TSX and Nasdaq shortly after closing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quipt Home Medical Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603052030PRIMZONEFULLFEED9667155) on March 06, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment